Search Results - "Ondrus, Janine"
-
1
Discovery of JNJ-63576253: A Clinical Stage Androgen Receptor Antagonist for F877L Mutant and Wild-Type Castration-Resistant Prostate Cancer (mCRPC)
Published in Journal of medicinal chemistry (28-01-2021)“…Persistent androgen receptor (AR) activation drives therapeutic resistance to second-generation AR pathway inhibitors and contributes to the progression of…”
Get full text
Journal Article -
2
Discovery of JNJ-63576253, a Next-Generation Androgen Receptor Antagonist Active Against Wild-Type and Clinically Relevant Ligand Binding Domain Mutations in Metastatic Castration-Resistant Prostate Cancer
Published in Molecular cancer therapeutics (01-05-2021)“…Numerous mechanisms of resistance arise in response to treatment with second-generation androgen receptor (AR) pathway inhibitors in metastatic…”
Get full text
Journal Article -
3
Abstract 2179: Antitumor activity of JNJ-63576253 (TRC253), a small molecule antagonist of F877L mutant and wild-type androgen receptor
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract Androgen receptor (AR) antagonists have transformed prostate cancer patient care by targeting a key nodal point in tumor cell signaling. However,…”
Get full text
Journal Article -
4
Spirocyclic Thiohydantoin Antagonists of F877L and Wild-Type Androgen Receptor for Castration-Resistant Prostate Cancer
Published in ACS medicinal chemistry letters (12-08-2021)“…Androgen receptor (AR) transcriptional reactivation plays a key role in the development and progression of lethal castration-resistant prostate cancer (CRPC)…”
Get full text
Journal Article -
5
Abstract 1319: Establishment and characterization of fresh primary human colorectal tumor implants
Published in Cancer research (Chicago, Ill.) (15-04-2012)“…Abstract A personalized approach towards the therapy of colorectal carcinoma is critical for a successful outcome. In recent years, direct transfer xenograft…”
Get full text
Journal Article